Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mushroom tyrosinase, primarily isolated from the common button mushroom Agaricus bisporus, is a copper-containing enzyme that serves as a rate-limiting catalyst in the production of melanin (UniProt: P00431). It possesses two distinct catalytic activities: monophenolase activity, which hydroxylates L-tyrosine to L-DOPA, and diphenolase activity, which oxidizes L-DOPA to dopaquinone (PubMed: 25553383). Although it is a fungal enzyme, it is the most widely used biochemical model for studying human tyrosinase due to its high homology, commercial availability, and ease of purification. In the pharmaceutical and cosmetic industries, it is the primary target for developing skin-lightening agents and treatments for hyperpigmentation disorders such as melasma and solar lentigines (PubChem: Tyrosinase). Inhibitors of this enzyme, such as kojic acid and hydroquinone, are used to reduce melanin synthesis, though they must be monitored for safety concerns like skin irritation and potential cytotoxicity. Beyond medicine, mushroom tyrosinase is also a focus of the food industry, where its inhibition is sought to prevent the enzymatic browning of produce.
Inhibition of the catalytic activity of tyrosinase, specifically blocking the hydroxylation of L-tyrosine (monophenolase activity) and the oxidation of L-DOPA to dopaquinone (diphenolase activity) to prevent melanin formation (PubMed: 29035199).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosinase (Agaricus bisporus) (PPO).